Ajanta Pharma informs about annual compliance report

13 May 2022 Evaluate
Ajanta Pharma has informed that it enclosed copy of the Annual Secretarial Compliance Report for year ended 31st March 2022 issued by Alwyn Dsouza & Co., Practicing Company Secretaries pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements), 2015.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

3061.75 67.65 (2.26%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.